Many people try topical skincare, supplements, or quick fix treatments that dont address internal recovery
Your submission has been received
Results BPC-157 dose-dependently decreased the number of flinches during phase 1 but did not decrease the number of flinches during phase 2
The test subjects were divided into two groups, where one group was presented with placebo for 84 days and the rest were presented daily with various concentrations of the peptide, for up to 84 days
Each tablet is manufactured to meet established quality standards and supplied in a bottle containing 100 tablets, offering a convenient format for consistent daily use
Injectable research peptides, like BPC-157 and TB-500, exploded in popularity last year, going from niche biohacker protocol to mainstream curiosity